Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-16 Sale | 2024-12-18 9:00 pm | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 10,000 | $12.42 | $124,200 | 202,014 (Direct) | View |
| 2024-11-18 Sale | 2024-11-20 9:31 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 7,246 | $10.78 | $78,112 | 109,885 (Direct) | View |
| 2024-11-18 Sale | 2024-11-20 9:30 pm | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 5,207 | $10.78 | $56,131 | 87,045 (Direct) | View |
| 2024-08-16 Sale | 2024-08-19 8:00 pm | Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer | 8,938 | $10.18 | $90,989 | 101,057 (Direct) | View |
| 2024-06-07 Sale | 2024-06-10 8:30 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 15,881 | $7.5 | $119,108 | 117,131 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:06 pm | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 2,218 | $6.47 | $14,350 | 92,252 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:06 pm | Replimune Group Inc. | REPL | Schwendenman Andrew Chief Accounting Officer | 2,298 | $6.47 | $14,868 | 38,238 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:05 pm | Replimune Group Inc. | REPL | Love Colin Chief Operating Officer | 17,615 | $6.47 | $113,969 | 777,345 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:04 pm | Replimune Group Inc. | REPL | Astley-Sparke Philip Executive Chairman | 37,928 | $6.47 | $245,394 | 1,487,350 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:02 pm | Replimune Group Inc. | REPL | Coffin Robert Director | 11,464 | $6.47 | $74,172 | 1,821,872 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:01 pm | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 20,194 | $6.47 | $130,655 | 212,014 (Direct) | View |
| 2024-05-16 Sale | 2024-05-20 8:00 pm | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 6,367 | $6.47 | $41,194 | 133,012 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-01 Option Award | 2025-04-03 8:06 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Peeples-Dyer Veleka Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:06 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 416,667 | $0 | 618,681 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:05 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Pucci Paolo Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:05 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Balachandran Madhavan Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:04 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 112,500 | $0 | 222,385 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:03 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Dhingra Kapil Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:02 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | SLATTERY JOSEPH P Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:02 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer | 112,500 | $0 | 213,557 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:01 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Weinand Dieter Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:01 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 112,500 | $0 | 199,545 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:00 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Oliger Christy J. Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2025-04-01 Option Award | 2025-04-03 8:00 pm | N/A 2035-04-01 | Replimune Group Inc. | REPL | Schwendenman Andrew Chief Accounting Officer | 83,333 | $0 | 121,571 (Direct) | View |
| 2025-03-05 Option Award | 2025-03-07 4:55 pm | N/A 2035-03-05 | Replimune Group Inc. | REPL | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 128,000 | $0 | 128,000 (Indirect) | View |
Ownership | 2025-03-07 4:52 pm | N/A N/A | Replimune Group Inc. | REPL | BAKER BROS. ADVISORS LP Baker Bros. Advisors (GP) LLC 667 L.P. Baker Brothers Life Sciences LP BAKER FELIX BAKER JULIAN Director 10% Owner | 0 | $0 | 25,103,489 (Indirect) | View |
| 2024-09-04 Option Award | 2024-09-05 8:10 pm | N/A 2034-09-04 | Replimune Group Inc. | REPL | Balachandran Madhavan Director | 64,000 | $0 | 64,000 (Direct) | View |
| 2024-08-30 Gift | 2024-08-30 8:00 pm | N/A N/A | Replimune Group Inc. | REPL | Astley-Sparke Philip Executive Chairman | 50,000 | $0 | 1,437,350 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:04 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Peeples-Dyer Veleka Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:03 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Patel Sushil Chief Executive Officer | 333,335 | $0 | 482,208 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:02 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Pucci Paolo Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:02 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Xynos Konstantinos Chief Medical Officer | 106,665 | $0 | 219,379 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:01 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Dhingra Kapil Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:01 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Hill Emily Luisa Chief Financial Officer | 106,665 | $0 | 189,995 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:01 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Sarchi Christopher Chief Commercial Officer | 88,900 | $0 | 161,145 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:01 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | SLATTERY JOSEPH P Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:00 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Weinand Dieter Director | 32,000 | $0 | 32,000 (Direct) | View |
| 2024-04-01 Option Award | 2024-04-03 8:00 pm | N/A 2034-04-01 | Replimune Group Inc. | REPL | Oliger Christy J. Director | 32,000 | $0 | 32,000 (Direct) | View |